Selected article for: "cell count and polymerase chain reaction"
Author: Zhang, Bin; Zhang, Jue; Chen, Hui; Chen, Luyan; Chen, Qiuying; Li, Minmin; Chen, Zhuozhi; You, Jingjing; Yang, Ke; Zhang, Shuixing
Title: Novel coronavirus disease 2019 (COVID-19): relationship between chest CT scores and laboratory parameters
  • Cord-id: vkzwcc9n
  • Document date: 2020_5_12
    • ID: vkzwcc9n
    Snippet: PURPOSE: To quantify the severity of 2019 novel coronavirus disease (COVID-19) on chest CT and to determine its relationship with laboratory parameters. METHODS: Patients with real-time fluorescence polymerase chain reaction (RT-PCR)–confirmed COVID-19 between January 01 and February 18, 2020, were included in this study. Laboratory parameters were retrospectively collected from medical records. Severity of lung changes on chest CT of early, progressive, peak, and absorption stages was scored
    Document: PURPOSE: To quantify the severity of 2019 novel coronavirus disease (COVID-19) on chest CT and to determine its relationship with laboratory parameters. METHODS: Patients with real-time fluorescence polymerase chain reaction (RT-PCR)–confirmed COVID-19 between January 01 and February 18, 2020, were included in this study. Laboratory parameters were retrospectively collected from medical records. Severity of lung changes on chest CT of early, progressive, peak, and absorption stages was scored according to the percentage of lung involvement (5 lobes, scores 1–5 for each lobe, range 0–20). Relationship between CT scores and laboratory parameters was evaluated by the Spearman rank correlation. The Bonferroni correction adjusted significance level was at 0.05/4 = 0.0125. RESULTS: A total of 84 patients (mean age, 47.8 ± 12.0 years [standard deviation]; age range, 24–80 years) were evaluated. The patients underwent a total of 339 chest CT scans with a median interval of 4 days (interquartile range, 3–5 days). Median chest CT scores peaked at 4 days after the beginning of treatment and then declined. CT score of the early stage was correlated with neutrophil count (r = 0.531, P = 0.011). CT score of the progressive stage was correlated with neutrophil count (r = 0.502, P < 0.001), white blood cell count (r = 0.414, P = 0.001), C-reactive protein (r = 0.511, P < 0.001), procalcitonin (r = 0.423, P = 0.004), and lactose dehydrogenase (r = 0.369, P = 0.010). However, CT scores of the peak and absorption stages were not correlated with any parameter (P > 0.0125). No sex difference occurred regarding CT score (P > 0.05). CONCLUSION: Severity of lung abnormalities quantified on chest CT might correlate with laboratory parameters in the early and progressive stages. However, larger cohort studies are necessary.

    Search related documents:
    Co phrase search for related documents
    • abnormality severity and acute respiratory syndrome: 1, 2
    • abnormality severity and lung abnormality: 1, 2, 3
    • abnormality severity and lung abnormality severity: 1, 2, 3
    • absorption peak and lung involvement: 1
    • absorption peak stage and acute respiratory syndrome: 1
    • absorption peak stage and lung involvement: 1, 2
    • absorption stage and acute respiratory syndrome: 1, 2
    • absorption stage and lung involvement: 1, 2
    • absorption stage peak and acute respiratory syndrome: 1
    • absorption stage peak and lung involvement: 1, 2
    • acute infection and low immune function: 1
    • acute infection and lung abnormality: 1, 2, 3, 4, 5
    • acute infection and lung abnormality severity: 1
    • acute respiratory syndrome and low immune function: 1, 2
    • acute respiratory syndrome and lung abnormality: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and lung abnormality severity: 1